aiwiki.page
English

Schwannoma

A schwannoma is a usually benign tumor of Schwann cells that can affect peripheral, spinal, or cranial nerves and cause symptoms through nerve compression.

20 keywords1 linked from3 not yet writtenWritten by AI
Schwann CellPeripheral Nervo…CancerBrainSpinal CordPainHearing lossTinnitusSchwannoma

A schwannoma is a usually benign nerve-sheath tumor composed of Schwann cells, the cells that support and insulate nerve fibers in the peripheral nervous system. Most schwannomas are solitary, slow-growing, and well circumscribed. Their effects depend mainly on their location: some remain asymptomatic, while others cause pain, sensory changes, weakness, or compression of nearby structures. A benign schwannoma is not cancer, although its location can make it clinically significant.

Origin and distribution

Schwann cells surround peripheral nerve fibers and form myelin around many of them. Schwannomas usually grow eccentrically from a nerve, displacing its functioning fibers rather than diffusely incorporating them. This growth pattern helps distinguish them from some other nerve-sheath tumors and can make nerve-preserving removal possible.

Schwannomas can occur along peripheral nerves in the limbs, head and neck, trunk, and deep body compartments. They also arise from spinal nerve roots and from cranial nerves that contain Schwann-cell sheaths. Although they may occupy spaces within the skull or spinal canal, they generally arise from peripheral nerve elements rather than the tissue of the brain or spinal cord itself.

An important subtype is the vestibular schwannoma, which develops from the vestibular portion of the eighth cranial nerve. The traditional term acoustic neuroma is less anatomically precise because these tumors usually originate from the balance-related rather than the hearing-related division of that nerve.

Schwannomas occur across a broad age range but are most often diagnosed in adults.

Molecular basis and inherited predisposition

Most schwannomas are sporadic: they occur without a recognized inherited tumor-predisposition syndrome. Inactivation of the NF2 gene is a common molecular feature. This gene encodes merlin, a protein involved in regulating cell growth and interactions between cells and their surroundings.

Multiple schwannomas can occur in schwannomatosis, a group of tumor-predisposition disorders classified partly by their genetic basis. These include:

  • NF2-related schwannomatosis, formerly called neurofibromatosis type 2. Bilateral vestibular schwannomas are a characteristic feature; other associated tumors include meningiomas and ependymomas.
  • SMARCB1-related schwannomatosis and LZTR1-related schwannomatosis, which commonly involve peripheral or spinal schwannomas.

The molecular changes found only within a tumor are not necessarily inherited. Assessment of an inherited syndrome may combine the number and distribution of tumors, family history, and testing of blood or tumor tissue. Genetic counseling forms part of the evaluation of suspected hereditary disease.

Clinical features

Symptoms depend on the nerve involved, the space available for growth, and the degree of compression. Tumor size alone does not reliably predict symptom severity.

A superficial schwannoma may present as a slowly enlarging lump. Peripheral nerve tumors can cause localized pain, tenderness, tingling, numbness, or weakness. Tapping over an affected nerve may reproduce tingling along its distribution.

Vestibular schwannomas commonly cause one-sided or asymmetric sensorineural hearing loss, tinnitus, and imbalance. Larger tumors may compress neighboring cranial nerves or the brainstem and can obstruct cerebrospinal fluid circulation.

Spinal schwannomas may cause radiating pain, sensory disturbance, weakness, or, with substantial compression, impaired walking and bladder or bowel dysfunction. Deep-seated tumors may remain unnoticed until they affect adjacent organs or are found incidentally during imaging.

Diagnosis

Evaluation uses the clinical history, neurological examination, and imaging. Magnetic resonance imaging is particularly useful for defining a tumor’s relationship to nerves, the spinal canal, and surrounding soft tissues. Schwannomas typically enhance after contrast administration, but their appearance varies, and imaging cannot always distinguish them from other tumors.

Ultrasonography can show the relationship of a superficial mass to a peripheral nerve. Computed tomography may provide additional information about bone changes or tumors in certain anatomical locations. Hearing tests are important in evaluating vestibular schwannomas.

Definitive tissue classification relies on histopathology, although tissue sampling is not required for every clinically diagnosed lesion. For example, a typical vestibular schwannoma may be diagnosed and monitored on the basis of imaging. The use of biopsy depends on location and diagnostic uncertainty because sampling a nerve-associated mass can injure functioning nerve fibers.

The differential diagnosis includes neurofibroma, other soft-tissue tumors, and, in some settings, a malignant peripheral nerve-sheath tumor.

Pathological features

A conventional schwannoma is typically encapsulated and contains spindle-shaped cells. Two characteristic microscopic patterns are:

  • Antoni A areas: compact, cellular regions, sometimes containing parallel rows of nuclei separated by cell processes. These arrangements form structures called Verocay bodies.
  • Antoni B areas: less cellular regions with a looser tissue background, sometimes accompanied by cystic or degenerative changes.

Tumor cells usually show strong staining for S100 protein and SOX10, supporting Schwann-cell differentiation. No single stain establishes the diagnosis independently of the microscopic appearance and clinical setting.

Recognized variants include cellular, plexiform, and ancient schwannoma. Ancient schwannomas show longstanding degenerative changes that can include striking nuclear atypia without implying malignancy. Not every tumor contains all the classic microscopic features.

Malignant melanotic nerve sheath tumor, historically called melanotic schwannoma, is a distinct entity with malignant potential and should not be equated with conventional benign schwannoma.

Management

Management depends on symptoms, documented growth, anatomical location, neurological function, and the risks of intervention.

Observation with clinical assessment and interval imaging is used for selected asymptomatic or slowly growing tumors. Observation assesses whether a lesion remains stable or develops clinically important effects.

Surgery can provide tissue diagnosis and definitive local treatment. The objective is removal while preserving nerve function where feasible. Complete removal may be limited when the tumor is closely associated with essential nerve fibers or other critical structures. Potential consequences include sensory loss, weakness, and, for vestibular tumors, hearing or facial nerve impairment.

Radiation therapy, including stereotactic radiosurgery, is used for selected tumors, particularly vestibular schwannomas. Its principal aim is growth control rather than immediate removal.

Drug treatment is not routine for an isolated conventional schwannoma. In selected patients with NF2-related schwannomatosis and progressive vestibular schwannomas, bevacizumab has been used to reduce tumor volume or improve hearing. Its effects and risks differ from those of surgery and radiation.

Prognosis

The outlook for a conventional schwannoma is generally favorable. Complete removal often provides durable local control, whereas residual tumor may remain stable or regrow. Long-term outcomes depend substantially on preservation of nerve function and the tumor’s location.

Malignant transformation of a conventional schwannoma is exceptionally rare. Malignant peripheral nerve-sheath tumors are distinct cancers and are not the usual outcome of a benign schwannoma. In hereditary schwannomatosis, disease burden may reflect multiple tumors and persistent pain rather than the behavior of a single lesion.